Recent developments in liposome-based veterinary therapeutics
- PMID: 24222862
- PMCID: PMC3809611
- DOI: 10.1155/2013/167521
Recent developments in liposome-based veterinary therapeutics
Abstract
Recent advances in nanomedicine have been studied in the veterinary field and have found a wide variety of applications. The past decade has witnessed a massive surge of research interest in liposomes for delivery of therapeutic substances in animals. Liposomes are nanosized phospholipid vesicles that can serve as delivery platforms for a wide range of substances. Liposomes are easily formulated, highly modifiable, and easily administered delivery platforms. They are biodegradable and nontoxic and have long in vivo circulation time. This review focuses on recent and ongoing research that may have relevance for veterinary medicine. By examining the recent developments in liposome-based therapeutics in animal cancers, vaccines, and analgesia, this review depicts the current significance and future directions of liposome-based delivery in veterinary medicine.
Figures
References
-
- Brayden DJ, Oudot EJM, Baird AW. Drug delivery systems in domestic animal species. Handbook of Experimental Pharmacology. 2010;199:79–112. - PubMed
-
- Underwood C, van Eps AW. Nanomedicine and veterinary science: the reality and the practicality. Veterinary Journal. 2012;193(1):12–23. - PubMed
-
- Irache JM, Esparza I, Gamazo C, Agüeros M, Espuelas S. Nanomedicine: novel approaches in human and veterinary therapeutics. Veterinary Parasitology. 2011;180(1-2):47–71. - PubMed
-
- Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discovery Today. 2003;8(24):1112–1120. - PubMed
-
- Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery. 2005;4(2):145–160. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous